Press Release

Cardiovascular Devices Market worth 16.6% CAGR by 2027

July, 2021

" COVID-19 Impact on Cardiovascular devices Market, size, share, growth, industry analysis, and forecast 2021-2027 "

Cardiovascular devices are used to manage heart conditions such as cardiac arrhythmias, heart failure, coronary artery disease, and congenital heart disease. These devices are used to fix heart conditions such as uneven heartbeats, malfunction of the heart, coronary thrombosis, damaged or diseased coronary arteries, mitral valve regurgitation, and congestive heart failure.

Owing to the leftover scars and pain caused by conventional surgeries, cardiac surgeons and patients have changed their preference toward minimally invasive procedures. MIS's key advantages are that these surgeries do not need big incisions; involve less hospitalization expenditure, owing to the shorter hospital stay; and result in rapid post-operative recovery compared to open surgery. Minimally Invasive Cardiac Surgery/Coronary Artery Bypass Grafting (MICS CABG) or the McGinn technique is a heart surgery performed through various small incisions instead of conventional open-heart surgery that requires a median sternotomy approach. Hence, a rising inclination towards minimally invasive surgeries is projected to propel market growth.

Request for sample copy of the report @

Various companies have been obtaining government approvals for the introduction and commercialization of cardiovascular devices. Along with this, the key market competitors are also acquiring other firms to increase their market share and further exhibit major growth. In addition, the rapid technological advancements in cardiovascular devices are providing significant opportunities for market growth.

The Cardiovascular Devices Market research report titled “Cardiovascular Devices Market by Device, Application, End User and Geography – Global Forecast to 2027.

Significant market players are Medtronic, Boston, B. Braun Melsungen AG, Becton, Dickinson and Company, General Electric Company, and Biosense Webster, Inc (Johnson and Johnson).

The increased adoption of advanced surgical treatments, increasing awareness about the commercially available products, and the existence of an exceptionally-sized target patient pool in the region contributing to the significant share of North America in the regional market.

Access full report summary @

The report consists of 95 Tables and 65 charts depicting the in-depth market study and the impact analysis of COVID-19. View detailed TOC here.

Cardiovascular Devices Market based on Device

  • Diagnostic and Monitoring Devices
  • Therapeutic and Surgical Devices
  • Others

Cardiovascular Devices Market based on Application

  • Coronary Heart Disease
  • Sudden Cardiac Arrest
  • Stroke
  • Cerebrovascular Heart Disease
  • Others

Cardiovascular Devices Market based on End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers

Cardiovascular Devices Market based on Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Mr. Karthick Subramani

Infoholic Research LLP

Marketing & Communication